Skip to main content
ALIVUS LIFE SCIENCES LIMITED logo

ALIVUS LIFE SCIENCES LIMITED — Investor Relations & Filings

Ticker · ALIVUS ISIN · INE03Q201024 LEI · 335800RYVA1DKP696G32 BSE.NS Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2023-04-27 Regulatory Filings
Country IN India
Listing BSE.NS ALIVUS

About ALIVUS LIFE SCIENCES LIMITED

https://www.alivus.com

Alivus Life Sciences Limited is a pharmaceutical organization dedicated to the formulation, production, and commercialization of a broad spectrum of healthcare solutions. The company operates across multiple therapeutic categories, including gastroenterology, anti-infectives, pain management, and nutritional supplements. Its product range includes diverse delivery formats such as tablets, capsules, syrups, and injectable medications. Alivus Life Sciences focuses on maintaining rigorous quality control protocols and manufacturing excellence to deliver reliable therapeutic outcomes. The company utilizes a robust distribution infrastructure to supply its pharmaceutical products to healthcare providers and patients, prioritizing the accessibility of essential medicines and the continuous expansion of its therapeutic portfolio.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the re-appointment of the statutory auditor for the company Glenmark Life Sciences Limited. It references compliance with SEBI Listing Regulations and provides details about the auditor's term and profile. The document does not contain any financial statements or detailed audit results but is an announcement regarding the auditor appointment. It is not an audit report itself, nor an annual report or interim report. The document is short (4991 characters) and serves as a regulatory announcement about a board decision related to auditors. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-04-27 English
Financial Result Updates
Regulatory Filings
2023-04-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a letter addressed to stock exchanges announcing an upcoming earnings call scheduled for April 28, 2023. It includes dial-in details and contact information for clarifications. The document does not contain any financial data, analysis, or results itself, but rather serves as an invitation or notification about the earnings call event. The document length is short (2526 characters), and it is clearly an announcement rather than the transcript or report of the earnings call. Therefore, it fits best under the category of Call Transcript (CT) announcements or invitations. However, since it is only an invitation and not the transcript itself, the closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event, because there is no specific category for earnings call invitations alone. Confidence is high due to clear content and format.
2023-04-20 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter dated April 19, 2023, addressed to stock exchanges (NSE and BSE) informing about an upcoming Board Meeting scheduled for April 27, 2023. The purpose of the meeting is to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2023. It also mentions the closure of the trading window for insiders as per SEBI regulations. The document does not contain any financial data or results itself, but is an announcement of a future event (Board Meeting) related to financial results approval. The document length is short (2207 characters) and it serves as a notification rather than the actual report or results. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories like Earnings Release or Annual Report. It is not a Board/Management Information filing because it does not announce changes in board or management, only a meeting notice.
2023-04-19 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter dated April 19, 2023, addressed to stock exchanges (NSE and BSE) informing about an upcoming Board Meeting scheduled for April 27, 2023. The purpose of the meeting is to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2023. It also mentions the closure of the trading window for insiders as per SEBI regulations. The document does not contain any financial data or results itself but is an announcement of a future event related to financial results approval. The document length is short (2207 characters) and it serves as a notification rather than the actual financial report or results. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification to exchanges about board meeting and financial results approval.
2023-04-19 English
Dividend
Notice of Dividend Amount Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the outcome of a Board Meeting held on March 16, 2023. The key content is the declaration of an Interim Equity Dividend for the financial year 2022-23, specifying the dividend amount, record date, and payment date. The document is short (2113 characters) and serves as an official announcement of a dividend declaration by the Board. It does not contain detailed financial statements or comprehensive financial data, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a Proxy Solicitation or Voting Results announcement. The primary purpose is to announce the dividend amount and payment details, which fits the category of Notice of Dividend Amount (DIV).
2023-03-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.